Literature DB >> 35699947

High-Titer Production of the Fungal Anhydrotetracycline, TAN-1612, in Engineered Yeasts.

Pedro A Baldera-Aguayo1,2, Arden Lee2, Virginia W Cornish2,3.   

Abstract

Antibiotic resistance is a growing global health threat, demanding urgent responses. Tetracyclines, a widely used antibiotic class, are increasingly succumbing to antibiotic resistance; generating novel analogues is therefore a top priority for public health. Fungal tetracyclines provide structural and enzymatic diversity for novel tetracycline analogue production in tractable heterologous hosts, like yeasts, to combat antibiotic-resistant pathogens. Here, we successfully engineered Saccharomyces cerevisiae (baker's yeast) and Saccharomyces boulardii (probiotic yeast) to produce the nonantibiotic fungal anhydrotetracycline, TAN-1612, in synthetic defined media─necessary for clean purifications─through heterologously expressing TAN-1612 genes mined from the fungus, Aspergillus niger ATCC 1015. This was accomplished via (i) a promoter library-based combinatorial pathway optimization of the biosynthetic TAN-1612 genes coexpressed with a putative TAN-1612 efflux pump, reducing TAN-1612 toxicity in yeasts while simultaneously increasing supernatant titers and (ii) the development of a medium-throughput UV-visible spectrophotometric assay that facilitates TAN-1612 combinatorial library screening. Through this multipronged approach, we optimized TAN-1612 production, yielding an over 450-fold increase compared to previously reported S. cerevisiae yields. TAN-1612 is an important tetracycline analogue precursor, and we thus present the first step toward generating novel tetracycline analogue therapeutics to combat current and emerging antibiotic resistance. We also report the first heterologous production of a fungal polyketide, like TAN-1612, in the probiotic S. boulardii. This highlights that engineered S. boulardii can biosynthesize complex natural products like tetracyclines, setting the stage to equip probiotic yeasts with synthetic therapeutic functionalities to generate living therapeutics or biocontrol agents for clinical and agricultural applications.

Entities:  

Keywords:  Saccharomyces boulardii; Saccharomyces cerevisiae; TAN-1612; anhydrotetracycline; efflux pumps

Mesh:

Substances:

Year:  2022        PMID: 35699947      PMCID: PMC9480237          DOI: 10.1021/acssynbio.2c00116

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.249


  87 in total

1.  Rapid liquid chromatographic method for simultaneous determination of tetracyclines antibiotics and 6-epi-doxycycline in pharmaceutical products using porous graphitic carbon column.

Authors:  L Monser; F Darghouth
Journal:  J Pharm Biomed Anal       Date:  2000-08-15       Impact factor: 3.935

2.  TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics.

Authors:  Wangrong Yang; Ian F Moore; Kalinka P Koteva; David C Bareich; Donald W Hughes; Gerard D Wright
Journal:  J Biol Chem       Date:  2004-09-27       Impact factor: 5.157

3.  A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics.

Authors:  Mark G Charest; Christian D Lerner; Jason D Brubaker; Dionicio R Siegel; Andrew G Myers
Journal:  Science       Date:  2005-04-15       Impact factor: 47.728

4.  Engineering Saccharomyces cerevisiae for production of simvastatin.

Authors:  Carly M Bond; Yi Tang
Journal:  Metab Eng       Date:  2018-09-10       Impact factor: 9.783

5.  Comparative characterization of fungal anthracenone and naphthacenedione biosynthetic pathways reveals an α-hydroxylation-dependent Claisen-like cyclization catalyzed by a dimanganese thioesterase.

Authors:  Yanran Li; Yit-Heng Chooi; Yuewei Sheng; Joan S Valentine; Yi Tang
Journal:  J Am Chem Soc       Date:  2011-09-14       Impact factor: 15.419

6.  Identifying the minimal enzymes required for anhydrotetracycline biosynthesis.

Authors:  Wenjun Zhang; Kenji Watanabe; Xiaolu Cai; Michael E Jung; Yi Tang; Jixun Zhan
Journal:  J Am Chem Soc       Date:  2008-04-19       Impact factor: 15.419

Review 7.  Synthetic biology and molecular genetics in non-conventional yeasts: Current tools and future advances.

Authors:  James M Wagner; Hal S Alper
Journal:  Fungal Genet Biol       Date:  2015-12-14       Impact factor: 3.495

8.  JCat: a novel tool to adapt codon usage of a target gene to its potential expression host.

Authors:  Andreas Grote; Karsten Hiller; Maurice Scheer; Richard Münch; Bernd Nörtemann; Dietmar C Hempel; Dieter Jahn
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

9.  Heterologous Catalysis of the Final Steps of Tetracycline Biosynthesis by Saccharomyces cerevisiae.

Authors:  Ehud Herbst; Arden Lee; Yi Tang; Scott A Snyder; Virginia W Cornish
Journal:  ACS Chem Biol       Date:  2021-07-16       Impact factor: 5.100

10.  Heterologous expression of MlcE in Saccharomyces cerevisiae provides resistance to natural and semi-synthetic statins.

Authors:  Ana Ley; Hilde Cornelijne Coumou; Rasmus John Normand Frandsen
Journal:  Metab Eng Commun       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.